Connection

Search Results to Kei Suzuki, MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Suzuki, Kei

PropertyValue
Research Expertise & Professional Interests Kei Suzuki, MD, is an Assistant Professor of Surgery in Cardiothoracic Surgery at the Boston University School of Medicine. He joined the university after completing his fellowship in Thoracic Surgery at New York Presbyterian Hospital. He is licensed in Japan and America and as of last year, he is a member of the Association for Surgical Education. For his research he has received over $200,000 in funding and has been a reviewer in the following publications: Digestive Diseases and Sciences, Cancer Immunology Immunotherapy, Tumori Journal, International Editorial Board, Annals of the American Thoracic Society, Diseases of the Esophagus, and Cancer Immunology Research. His research interests are Lung Cancer, Esophageal Cancer/Disease, and Mediastinal Disease.

One or more keywords matched the following items that are connected to Suzuki, Kei

Item TypeName
Concept Bone Neoplasms
Concept Breast Neoplasms
Concept Cancer Care Facilities
Concept Esophageal Neoplasms
Concept Lung Neoplasms
Concept Neoplasms
Concept Neoplasms, Glandular and Epithelial
Concept Pleural Neoplasms
Award or Honor Receipt Finalist
Academic Article Detection of Recurrence Patterns After Wedge Resection for Early Stage Lung Cancer: Rationale for Radiologic Follow-Up.
Academic Article Postinduction positron emission tomography assessment of N2 nodes is not associated with ypN2 disease or overall survival in stage IIIA non-small cell lung cancer.
Academic Article Resection of Primary and Secondary Tumors of the Sternum: An Analysis of Prognostic Variables.
Academic Article Mesothelin overexpression is a marker of tumor aggressiveness and is associated with reduced recurrence-free and overall survival in early-stage lung adenocarcinoma.
Academic Article Clinical impact of immune microenvironment in stage I lung adenocarcinoma: tumor interleukin-12 receptor ß2 (IL-12Rß2), IL-7R, and stromal FoxP3/CD3 ratio are independent predictors of recurrence.
Academic Article FDG-PET SUVmax combined with IASLC/ATS/ERS histologic classification improves the prognostic stratification of patients with stage I lung adenocarcinoma.
Academic Article High SUVmax on FDG-PET indicates pleomorphic subtype in epithelioid malignant pleural mesothelioma: supportive evidence to reclassify pleomorphic as nonepithelioid histology.
Academic Article A grading system combining architectural features and mitotic count predicts recurrence in stage I lung adenocarcinoma.
Academic Article An in vivo platform for tumor biomarker assessment.
Academic Article A nuclear grading system is a strong predictor of survival in epitheloid diffuse malignant pleural mesothelioma.
Academic Article Immune responses and immunotherapeutic interventions in malignant pleural mesothelioma.
Academic Article Chronic inflammation in tumor stroma is an independent predictor of prolonged survival in epithelioid malignant pleural mesothelioma patients.
Academic Article Prognostic immune markers in non-small cell lung cancer.
Academic Article Pleomorphic epithelioid diffuse malignant pleural mesothelioma: a clinicopathological review and conceptual proposal to reclassify as biphasic or sarcomatoid mesothelioma.
Academic Article Palliation and pleurodesis in malignant pleural effusion: the role for tunneled pleural catheters.
Academic Article Initial surgical experience following implementation of lung cancer screening at an urban safety net hospital.
Academic Article Definitive treatment patterns and survival in stage II non-small cell lung cancer.
Academic Article Esophageal Cancer Presentation, Treatment, and Outcomes Vary With Hospital Safety-Net Burden.
Academic Article Induction chemoradiation is associated with improved survival in chest wall invasion lung cancer.
Academic Article Multidisciplinary Therapy of Esophageal Cancer.

Highlights
Search Criteria
  • Cancer
  • Immunology